Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease

被引：2
作者：
Ritz, E. [1 ]
Pitt, B. [2 ]
机构：
[1] Heidelberg Univ, Nierenzentrum, Heidelberg, Germany
[2] Univ Michigan, Med Sch, Internal Med & Cardiovasc Dis, Ann Arbor, MI 48109 USA
来源：
CLINICAL KIDNEY JOURNAL | 2013年 / 6卷 / 05期
关键词：
aldosterone blockade; chronic kidney disease; hyperkalaemia; potassium binder;
D O I：
10.1093/ckj/sft084
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Hyperkalaemia continues to be a major hazard of mineralocorticoid receptor blockade in an effort to retard the progression of chronic kidney disease (CKD). In cardiac patients on mineralocorticoid receptor blockade, RLY-5016 which captures K+ in the colon has been effective in reducing the risk of hyperkalaemia. This compound might be useful in CKD as well.
引用
收藏
页码：464 / 468
页数：5
相关论文
共 63 条
[1]   Regression of existing glomerulosclerosis by inhibition of aldosterone [J].
Aldigier, JC ;
Kanjanbuch, T ;
Ma, LJ ;
Brown, NJ ;
Fogo, AB .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3306-3314
[2]   Aldosterone Synthase Inhibition With LCI699 A Proof-of-Concept Study in Patients With Primary Aldosteronism [J].
Amar, Laurence ;
Azizi, Michel ;
Menard, Joel ;
Peyrard, Severine ;
Watson, Catherine ;
Plouin, Pierre-Francois .
HYPERTENSION, 2010, 56 (05) :831-+
[3]   Nongenomic vascular action of aldosterone in the glomerular microcirculation [J].
Arima, S ;
Kohagura, K ;
Xu, HL ;
Sugawara, A ;
Abe, T ;
Satoh, F ;
Takeuchi, K ;
Ito, S .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :2255-2263
[4]   Aldosterone synthase inhibition in humans [J].
Azizi, Michel ;
Amar, Laurence ;
Menard, Joel .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) :36-43
[5]   Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance An Early Contributor to Diabetes-Related Vascular Disease? [J].
Bender, Shawn B. ;
McGraw, Adam P. ;
Jaffe, Iris Z. ;
Sowers, James R. .
DIABETES, 2013, 62 (02) :313-319
[6]   Change in proteinuria after adding aldosterone Blockers to ACE inhibitors or angiotensin receptor Blockers in CKD: A systematic review [J].
Bomback, Andrew S. ;
Kshirsagar, Abhijit V. ;
Amamoo, M. Ahinee ;
Klemmer, Philip J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (02) :199-211
[7]   Renal aspirin: will all patients with chronic kidney disease one day take spironolactone? [J].
Bomback, Andrew S. ;
Kshirsagar, Abhijit V. ;
Klemmer, Philip J. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2009, 5 (02) :74-75
[8]   Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations [J].
Boscaro, Marco ;
Giacchetti, Gilberta ;
Ronconi, Vanessa .
BRAIN AND OBESITY, 2012, 1264 :87-102
[9]  
Buysse JM, 2012, FUTUR CARDIOL, V8, P17, DOI [10.2217/fca.11.71, 10.2217/FCA.11.71]
[10]   Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial [J].
Calhoun, David A. ;
White, William B. ;
Krum, Henry ;
Guo, Weinong ;
Bermann, Georgina ;
Trapani, Angelo ;
Lefkowitz, Martin P. ;
Menard, Joel .
CIRCULATION, 2011, 124 (18) :1945-U124
1234567